Acadia Pharma GAAP EPS of $0.20 beats by $0.06, revenue of $250.4M beats by $1.56M Posted on November 6, 2024 by wpadmin Acadia Pharma press release (NASDAQ:ACAD): Q3 GAAP EPS of $0.20 beats by $0.06. Revenue of $250.4M (+18.3% Y/Y) beats by $1.56M.